文献速递心力衰竭与心肌病冠心病

心肌细胞分泌组分析识别PCSK6为心肌梗死后心脏重构新因子

Secretome Analysis of Cardiomyocytes Identifies PCSK6 (Proprotein Convertase Subtilisin/Kexin Type 6) as a Novel Player in Cardiac Remodeling After Myocardial Infarction.
PubMed 文献 · Circulation · 2020-02-26

研究建立基于稳定同位素标记与点击化学结合质谱的原代心肌细胞分泌组分析方法,在无血清饥饿条件下鉴定缺氧后24小时内分泌的1026种蛋白,发现PCSK6为缺氧上调最显著的分泌因子之一。小鼠左前降支结扎及人血清ELISA验证PCSK6在心肌梗死后第3天达峰,机制上PCSK6通过影响成纤维细胞TGF-β激活与SMAD3转位促进胶原表达和心脏纤维化,加重左室功能下降。

要点

  • 新方法可无血清饥饿分析原代心肌细胞分泌组,24小时鉴定1026种蛋白。
  • PCSK6在缺氧心肌细胞及梗死后小鼠心脏中表达升高,人血清梗死后第3天达峰。
  • 心肌细胞特异性过表达PCSK6加重梗死后胶原表达、纤维化及左室功能下降。

核心结论

  • 缺氧心肌细胞分泌的PCSK6通过促进成纤维细胞胶原表达和心脏纤维化,参与急性心肌梗死后心脏重构。

研究设计与样本

  • 研究采用稳定同位素标记与点击化学结合质谱建立原代心肌细胞分泌组分析,并开展ELISA人样本检测、小鼠左前降支结扎及AAV9介导的心肌细胞特异性体内过表达验证。

主要发现

  • 该分泌组方法无需血清饥饿即可分析原代心肌细胞分泌组,24小时内鉴定1026种分泌蛋白,较先前方法检测量增加5倍。
  • 缺氧上调最显著的分泌因子之一为PCSK6,缺氧心肌细胞中PCSK6 mRNA和蛋白水平均升高。
  • 小鼠左前降支结扎3天后心脏PCSK6表达升高,免疫组化证实该结果。
  • 人血清ELISA显示急性心肌梗死患者PCSK6呈明显动力学变化,梗死后第3天达峰。
  • 转移PCSK6缺失的心肌细胞分泌组使成纤维细胞I型和III型胶原表达低于对照,siRNA敲低心肌细胞PCSK6影响成纤维细胞TGF-β激活与SMAD3转位;AAV9介导心肌细胞特异性过表达PCSK6则增加梗死后胶原表达和心脏纤维化并降低左室功能。

临床怎么用

  • PCSK6可作为心肌梗死后心脏重构的潜在生物标志物和干预靶点,但尚需临床转化验证。

局限性

  • 原文摘要未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Acute occlusion of a coronary artery results in swift tissue necrosis. Bordering areas of the infarcted myocardium can also experience impaired blood supply and reduced oxygen delivery, leading to altered metabolic and mechanical processes. Although transcriptional changes in hypoxic cardiomyocytes are well studied, little is known about the proteins that are actively secreted from these cells. METHODS: We established a novel secretome analysis of cardiomyocytes by combining stable isotope labeling and click chemistry with subsequent mass spectrometry analysis. Further functional validation experiments included ELISA measurement of human samples, murine left anterior descending coronary artery ligation, and adeno-associated virus 9-mediated in vivo overexpression in mice. RESULTS: The presented approach is feasible for analysis of the secretome of primary cardiomyocytes without serum starvation. A total of 1026 proteins were identified to be secreted within 24 hours, indicating a 5-fold increase in detection compared with former approaches. Among them, a variety of proteins have not yet been explored in the context of cardiovascular pathologies. One of the secreted factors most strongly upregulated upon hypoxia was PCSK6 (proprotein convertase subtilisin/kexin type 6). Validation experiments revealed an increase of PCSK6 on mRNA and protein level in hypoxic cardiomyocytes. PCSK6 expression was elevated in hearts of mice after 3 days of ligation of the left anterior descending artery, a finding confirmed by immunohistochemistry. ELISA measurements in human serum also indicate distinct kinetics for PCSK6 in patients with acute myocardial infarction, with a peak on postinfarction day 3. Transfer of PCSK6-depleted cardiomyocyte secretome resulted in decreased expression of collagen I and III in fibroblasts compared with control treated cells, and small interfering RNA-mediated knockdown of PCSK6 in cardiomyocytes impacted transforming growth factor-β activation and SMAD3 (mothers against decapentaplegic homolog 3) translocation in fibroblasts. An adeno-associated virus 9-mediated, cardiomyocyte-specific overexpression of PCSK6 in mice resulted in increased collagen expression and cardiac fibrosis, as well as decreased left ventricular function, after myocardial infarction. CONCLUSIONS: A novel mass spectrometry-based approach allows investigation of the secretome of primary cardiomyocytes. Analysis of hypoxia-induced secretion led to the identification of PCSK6 as being crucially involved in cardiac remodeling after acute myocardial infarction.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Kuhn TC, Knobel J, Burkert-Rettenmaier S, et al. Secretome Analysis of Cardiomyocytes Identifies PCSK6 (Proprotein Convertase Subtilisin/Kexin Type 6) as a Novel Player in Cardiac Remodeling After Myocardial Infarction. Circulation. 2020. PMID: 32100557. doi:10.1161/CIRCULATIONAHA.119.044914

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。